New Year brings New PBS listings

The first day of the new year brought with it new hope for Australians fighting one of the most common blood cancers, thanks to a critical new medicine listed on the Pharmaceutical Benefits Scheme (PBS).On 1st January 2021, Darzalex® (daratumumab) was listed for the first time in combination with bortezomib and dexamethasone, as a second-line…

Details

Vale Doug Anthony

I am very sad to hear of the passing of Doug Anthony today.   I always felt I was in the presence of a legend when I was with Doug.   He was always easy with a warm smile and interest in how you were going.   The Nationals are 100 years old this year…

Details

PBS support for Australians living with leukaemia

Patients living with one of Australia’s most common forms of leukaemia are set to benefit from expanded access to a breakthrough medicine through the Pharmaceutical Benefits Scheme (PBS).   From 1 December, access to Venclexta® (venetoclax) will be extended in combination with obinutuzumab for the first-line treatment of patients with chronic lymphocytic leukaemia who have…

Details

Life-saving SMA medicine to be made available to Australian babies

Access to a life-saving and life-changing medicine will soon be expanded for Australian children and infants with Spinal Muscular Atrophy (SMA).   From 1 December, subsidised access to the life-changing medicine Spinraza® (nusinersen) will be expanded on the Pharmaceutical Benefits Scheme (PBS). It will include children and infants genetically diagnosed with the most severe types…

Details